Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Frontiers | Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis
JCM | Free Full-Text | Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer – Consult QD
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies | British Journal of Cancer
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram
Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival - IOS Press
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram
